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Objective: Previous investigations into the relationship between late-life depressive symptoms and cog-
nitive functioning have resulted in mixed findings concerning whether or not depressive symptoms and
cognitive functioning are related. The mixed reports may be due in part to differences in clinical and
nonclinical samples and to inadequate consideration of the dynamic nature (i.e., fluctuating course)
of depressive symptoms and cognitive functioning in older adults. The current study examined the
chronic, acute, and longitudinal relationships between depressive symptoms and cognitive functioning
in older adults in an ongoing treatment study of major depressive disorder (MDD).
Methods:The neurocognitive outcomes of depression in the elderly study operates in a naturalistic treat-
ment milieu using a pharmacological treatment algorithm and regular psychiatric assessment. Four
hundred and fifty-three older adults [mean age 70years, standard deviation (SD)=7.2] meeting criteria
for MDD at study enrollment received annual neuropsychological testing and depressive symptom
monitoring for an average of 8.5 years (SD=4.5).
Results:Hierarchical linear modeling revealed that higher age, lower education, and higher average/chronic
levels of depressive symptoms were related to lower cognitive functioning. Additionally, results revealed
that when an individual’s depressive symptoms are higher than is typical for a specific individual, general
cognitive function was worse than average. There was no evidence of lagged/longitudinal relationships be-
tween depressive symptoms and cognitive functioning in older adults in treatment for MDD.
Conclusions: Cognitive functioning and depressive symptoms are concurrently associated in older
adults with MDD, highlighting the potential importance for stabilizing mood symptoms as a means
to manage cognitive deficits in late-life depression. Copyright # 2015 John Wiley & Sons, Ltd.
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Introduction
The presence of both subclinical depressive symp-
toms and clinical depressive symptoms are quite
common in older adults, with prevalence estimates
reported at 9.8% and 2.3–4.8%, respectively (Byers
et al., 2010; Gum et al., 2009; Meeks et al., 2011). De-
pression is related to a number of negative outcomes
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among older adults, including increased rates of
healthcare utilization (Feng et al., 2009) and costs
(Katon et al., 2003), poor sleep (Buysse, 2004), care-
giver burden (Morrow-Howell and Proctor, 1998),
and increased mortality (Schulz et al., 2002). Decades
of anecdotal clinical reports suggest that older adults
with significantly elevated levels of depressive symp-
toms also experience decrements in cognitive func-
tioning. Such clinical data have fueled empirical
investigations into the relationships between late-life
depressive symptoms and cognitive functioning; how-
ever, these investigations have not produced consis-
tent results (e.g., Dotson et al., 2008; Han et al.,
2006). Potential explanations for the disparate results
include investigation of these relationships in non-
clinical samples of older adults and the fluctuating
course of both late-life cognitive functioning
(Dzierzewski et al., 2013; Hultsch et al., 2002) and
late-life depression (Beekman et al., 2002; Dautovich
et al., 2014). The present investigation sought to in-
vestigate the relationships between depressive symp-
toms and cognitive functioning across the treatment
history of late-life major depressive disorder (MDD).
Cross-sectional investigations examining the rela-
tionship between depressive symptoms and cognitive
functioning in late-life have consistently reported a
significant negative relationship between depressive
symptoms and cognitive functioning (Dotson et al.,
2008; Ganguli et al., 2006; Lichtenberg et al., 1995;
Vinkers et al., 2004). However, the longitudinal
relationship between depressive symptoms and
cognitive functioning has not been observed as con-
sistently. Several longitudinal examinations indicate
that initial levels of depressive symptoms are unrelated
to longitudinal decline in cognitive functioning in
older adults (Ganguli et al., 2006; Han et al., 2006),
whereas other investigators report that depressive
symptoms are related to subsequent cognitive decline
(Dotson et al., 2008; van den Kommer et al., 2013;
Wilson et al., 2004). Notably, participants in the
aforementioned studies were generally not selected
for study inclusion on the basis of their depressive
symptoms.
Alternatively, some investigators have suggested that
cognitive functioning may be a prodromal predictor of
subsequent changes in depressive symptoms. It has
been reported that older adults with worse baseline
cognitive functioning had an accelerated increase of
depressive symptoms; however, individuals with worse
depressive symptoms at baseline did not have an accel-
eration in cognition decline (Jajodia and Borders,
2011; Perrino et al., 2008; Vinkers et al., 2004). As these
studies did not select their samples based on clinical
diagnosis of depressive symptoms, authors have specu-
lated that “individuals with stronger clinical histories
might experience a different process” (Jajodia & Bor-
ders, 2011).
In addition to the distinction between clinical and
subclinical depressive symptoms, some of the dispa-
rate findings regarding the relationship between de-
pressive symptoms and cognitive functioning may be
in part due to the fluctuating nature of both late-life
depression and late-life cognitive functioning. Depres-
sive disorders in older adults are characterized by
“prolonged fluctuating symptoms” (i.e., variability
among individual symptoms over time) (Beekman
et al., 2002) with a “fluctuating course” (i.e., changes
in the overall symptom severity) (Sanders et al.,
2011). Dautovich, Dzierzewski, and Gum (2014)
reported that among older adults with clinically rele-
vant levels of depression, depressive symptoms fluctu-
ated greatly from observation to observation
(Dautovich et al., 2014). Likewise, the cognitive
functioning (as operationalized by cognitive test per-
formance) of nondepressed, community-dwelling
older adults also fluctuates greatly from occasion to
occasion (Dzierzewski et al., 2013; Hultsch et al.,
2002), with the amount of fluctuation often being re-
ported as an important predictor of cognitive plastic-
ity, dementia status, and even death (Dzierzewski
et al., 2013; Hultsch et al., 2000; MacDonald et al.,
2008). Previous research into the fluctuating nature
of both depressive symptoms and cognitive function-
ing suggests that concomitant fluctuations in depres-
sive symptoms may contribute to the variability of
cognitive performance over time. In fact, it has been
reported that at an assessment when depressive symp-
toms worsened, general cognitive functioning also
worsened (Han et al., 2006). However, like other stud-
ies into the relationship between depressive symptoms
and cognitive functioning, the sample was not selected
on the basis of the presence of clinically significant de-
pressive symptoms.
The referenced studies portray a rather complex re-
lationship between late-life depressive symptoms and
cognitive functioning, with questions remaining re-
garding the directionality of the relationships and
whether previous findings in nonclinical samples
may generalize to clinically depressed older adults un-
der treatment. We sought to address these questions
by examining the relationships between depressive
symptoms and cognitive functioning in a sample of
older adults under long-term treatment for MDD.
Specific aims of the investigation were the following:
(i) to examine the bidirectional relationships between
chronic depressive symptoms and cognitive
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functioning in older adults under treatment for MDD;
(ii) to examine the bidirectional relationships between
concurrent intrapersonal fluctuations in depressive
symptoms and intrapersonal changes in cognitive
functioning in older adults with MDD; and (iii) to ex-
amine the bidirectional cross-lagged relationships be-
tween depressive symptoms and subsequent cognitive
functioning in older adults under treatment for
MDD. We hypothesized the following: (i) depressive
symptoms and cognitive functioning would be chron-
ically related; (ii) depressive symptoms and cognitive
functioning would be acutely related; and (iii) there
would be a lagged relationship (1-year longitudinal)
between depressive symptoms and subsequent cogni-
tive functioning (but not vice versa) in older adults
under treatment for MDD.
Methods
Participants
All participants were enrolled in the National Institute
of Mental Health-sponsored Mental Health Clinical
Research Center, neurocognitive outcomes of depres-
sion in the elderly (NCODE) study at Duke University
Medical Center (Steffens et al., 2004). Participants
were 60years or older with a diagnosis of MDD at
the time of enrollment. Exclusion criteria at the time
of enrollment included the following: (i) another ma-
jor psychiatric illness (bipolar disorder, schizophrenia,
and dementia); (ii) alcohol/drug abuse or dependence;
and (iii) primary neurologic illness. All individuals
were screened for vision, hearing, and motor limita-
tions that may interfere with valid neuropsychological
test administration, and no participants were excluded
on the basis of screening results. Individuals were
screened for dementia at time of enrollment on the
basis of an established study protocol that included re-
view of a comprehensive clinical evaluation, consulta-
tion with referring physicians, and cognitive screening
with the mini-mental state examination (MMSE;
Folstein et al., 1975). Clinicians were allowed to ex-
clude participants if clinical or medical history was
suspicious for cognitive decline; however, none of
the participants were excluded because of suspected
dementia. Additionally, individuals performing <25
on the MMSE were reassessed after an 8-week phase
of treatment and subsequently included for longitudi-
nal follow-up if their MMSE score was ≥25 at that
time. No individuals were excluded because of low
MMSE. NCODE was approved by the Duke University
Institutional Review Board.
Design and measures
At the time of study enrollment, a geriatric psychiatrist
interviewed each participant and assessed depression
symptoms with a number of standardized clinical as-
sessments (Steffens et al., 2004). The clinical interview
included the 10-item Montgomery–Asberg Depres-
sion Rating Scale (MADRS; Montgomery and Asberg,
1979). The MADRS has a range of 0–60 (higher scores
representing more depressive symptoms) and was re-
peated at annual assessments. Scores on the MADRS
>15 indicate clinically meaningful levels of depressive
symptoms, with scores >35 indicating severe depres-
sion. The MADRS has demonstrated good psychomet-
ric properties within the NCODE study (Steffens et al.,
2004) and has been validated for use in geriatric pa-
tients (Engedal et al., 2012). The NCODE study
operates in a naturalistic treatment milieu using treat-
ment guidelines established by the Duke Affective Dis-
orders Program (Steffens et al., 2002). The majority of
individuals were treated with a selective serotonin-
reuptake inhibitor as a first-line treatment, with
changes in treatment procedures based on the treat-
ment response and the Duke Somatic Treatment Algo-
rithm for Geriatric Depression (Steffens et al., 2002).
The protocol recommends that patients receive
continuation treatment for at least 1–2years (some
indefinitely) once they achieve remission. Neu-
ropsychological assessment occurred at study enroll-
ment and was repeated annually. The assessment
included the Consortium to Establish a Registry for
Alzheimer’s Disease (CERAD) neuropsychological
battery (Morris et al., 1989). The current study used
the CERAD Total Score (CERAD-TS; Chandler et al.,
2005), as an index of global neurocognitive function-
ing. The CERAD-TS includes measures of immediate
memory, delayed memory, recognition memory, se-
mantic fluency, object naming, and constructional
praxis, with a score ranging from 0 to 100 with higher
scores indicating better cognitive functioning. The
complete study design, including assessment of de-
pressive symptoms and neuropsychological assess-
ment have been described in detail elsewhere
(Steffens et al., 2004). The current study utilized the
annual CERAD-TS and MADRS scores.
Statistical analysis
Data were analyzed with IBM SPSS 22 statistical
software. Statistical analysis addressed the bidirec-
tional relationship between chronic depressive
symptoms and cognitive functioning in older adults
1078 J. M. Dzierzewski et al.
Copyright # 2015 John Wiley & Sons, Ltd. Int J Geriatr Psychiatry 2015; 30: 1076–1084
under treatment for MDD (aim 1), the bidirectional
relationship between concurrent (i.e., acute) intraper-
sonal fluctuations in depressive symptoms and
intrapersonal changes in cognitive functioning in
older adults with MDD (aim 2), and the bidirectional
1-year lagged (i.e., longitudinal) relationship between
depressive symptoms and subsequent cognitive
functioning in older adults under treatment for
MDD (aim 3). The first step was to determine whether
the current clinically depressed sample displayed
sufficient fluctuation in cognitive functioning and
depressive symptoms to justify the examination of
dynamic relationships between depression and cogni-
tion. This was accomplished through implementation
of a predictor-free hierarchical linear model (HLM;
Singer and Willett, 2003) and calculation of the
intraclass correlation coefficient [ICC: σ2(between)/
σ2(between+within)].
To accomplish the primary study aims, depressive
symptoms (i.e., MADRS scores) were used to predict
cognitive functioning (i.e., CERAD-TS) within an
HLM framework. In order to examine the direction of
the depressive symptoms–cognitive functioning relation-
ship, we also used cognitive functioning (i.e., CERAD-
TS) to predict depressive symptoms (i.e., MADRS
scores). Such an approach provided an opportunity
to examine how well depressive symptoms predicted
cognitive functioning (and vice versa) both concur-
rently and 1-year lagged within-persons (level 1) and
between-persons (level 2). Level 2 submodels exam-
ined questions such as: Do people who generally exhibit
more depressive symptoms (i.e., higher chronic depres-
sion) also experience lower levels of cognitive functioning?
Concurrent level 1 submodels addressed questions re-
lated to acute changes, such as: When a person exhibits
depressive symptoms above their personal average, does
he or she also experience relative decreased cognitive func-
tioning? Lagged level 1 submodels addressed longitudi-
nal questions such as: A year after an assessment when
a person exhibits above-average depressive symptoms,
does he or she experience a subsequent decrease in cogni-
tive functioning? As such, this study sought to address
the chronic, acute, and longitudinal associations
among depressive symptoms and cognitive functioning
(and vice versa). Participant attrition and missing data
are common problems in longitudinal designs. How-
ever, participants with missing data are not excluded
from analyses within an HLM framework, as all avail-
able data are utilized in analyses via maximum likeli-
hood estimates. All models controlled for the
following covariates: linear and quadratic time trends,
age, education level, sex, and age×time trends
interactions.
In follow-up analyses, the aforementioned models
predicting cognitive functioning were rerun to explore
the possibility that baseline depressive symptoms
may be overinfluencing the model. All participants
carried a diagnosis of MDD upon entry to the study.
As the study design was a naturalistic treatment
milieu, study participants received treatment aimed
at reducing depressive symptoms. As such, depressive
symptomology was expected to be highest at study
entry, which could result in undue model influence.
To test this idea, all models were reparameterized re-
moving baseline values of the MADRS and examined
for change in model estimates.
Results
Descriptive statistics
Data from 453 older adults were analyzed. Participants
had an average age of 70 years (standard deviation
(SD)=7.2] at study enrollment, completed 14years
of schooling, (SD=3.0), experienced a mild level of
depressive symptoms on average throughout their
time in the study (mean MADRS 14±8.5), and were
enrolled in the study for an average of 8.5 years
(SD=4.5). Study participants provided an average of
5.6 data points (range 1–13). The mean cognitive
functioning (CERAD-TS across time and participants)
was 74 (SD=12.3) (Table 1).
Fluctuations in cognition and depressive symptoms
The ICC was 0.78 for CERAD-TS, indicating that 22%
of the overall variance in cognitive functioning was a
within-person (i.e., over time) phenomenon. The
Table 1 Demographic and clinical data (n = 453)
Mean (SD)
Age 70 (7.2)
Education 14 (3.0)
Number of visits 5.6 (2.9)
Years in study 8.5 (4.5)
Sex (% female) 68
Race (% White) 85
Marital status (% married) 59
MADRS (initial) 23 (6.8)
CERAD-TS (initial) 76 (12)
MADRS (average) 14 (8.5)
CERAD-TS (average) 74 (12.3)
SD, standard deviation; MADRS, Montgomery–Asberg Depression
Rating Scale; CERAD-TS, Consortium to Establish a Registry for
Alzheimer’s Disease neuropsychological battery, Total Score.
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ICC was 0.33 for MADRS, indicating that 67% of the
overall variance in depressive symptoms was a
within-person phenomenon. See Figure 1 for a graph-
ical representation of individual CERAD-TS and
MADRS across the study period. As illustrated in
Figure 1, an individual’s unique cognitive functioning
and depressive symptoms varied widely from assess-
ment to assessment, suggesting that our conceptual
and analytic approach was appropriate.
Depressive symptoms predicting cognitive functioning
In the HLM predicting concurrent cognitive func-
tioning, average level of depressive symptoms
[B=0.37, t(294)=3.77, p<0.001] was a signifi-
cant between-person (level 2) predictor, as was age
[B=0.31, t(484)=3.03, p<0.01] and education
[B=1.54, t(285)=6.65, p<0.001]. Older adults with
higher levels of chronic depressive symptoms had
lower-than-average overall cognitive functioning. At
the within-person level (level 1), person-centered de-
pressive symptoms [B=0.11, t(152)=3.41,
p<0.01] was a significant predictor of cognitive func-
tion. This model revealed an acute relationship; when
an individual exhibited depressive symptoms that are
above their intrapersonal average, they also displayed
worse cognitive functioning than average. Other level
1 significant predictors included quadratic time
[B=0.51, t(163)=2.14, p<0.05] and the age×quadratic
time interaction [B=0.01, t(167)=2.23, p<0.05],
suggesting that older participants demonstrated
accelerated decline in cognitive functioning. The
model explained 43% of the within-person variance
and 40% of the between-person variance in cognitive
functioning. The lagged model was not suggestive of
a longitudinal relationship. Depressive symptoms do
not predict cognitive functioning 1 year later in older
adults under treatment for MDD (Table 2).
In follow-up analysis examining the potential
overinfluence of baseline depressive symptoms, the
model resulted in an identical pattern of results and
significance, indicating no undue influence of baseline
level of depressive symptoms on the model observed
relationships between depressive symptoms and cog-
nitive functioning.
Cognitive functioning predicting depressive symptoms
The final HLM predicting concurrent depressive
symptoms revealed a similar pattern of results as those
for the model predicting cognitive functioning. Older
adults and individuals with better average cognitive
functioning had lower than average overall chronic
depressive symptoms. Additionally, older individuals
exhibited accelerated decline in depressive symptoms,
and when an individual exhibited acute cognitive
functioning above their intrapersonal average, they
also displayed acute lower depressive symptoms than
average. Again, the lagged model did not suggest that
cognitive functioning predicted 1-year longitudinal
change in depressive symptoms in older adults under
treatment for MDD (Table 3).
Figure 1 Graph showing within-person fluctuations in cognitive functioning [Consortium to Establish a Registry for Alzheimer’s Disease neuropsy-
chological battery, Total Score (CERAD-TS), right panel] and depressive symptoms [Montgomery–Asberg Depression Rating Scale (MADRS), left
panel] across study period. Each individual’s data is represented by a single line.
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Discussion
Consistent with previous research (Dzierzewski et al.,
2013; Hultsch et al., 2002), we observed large fluctua-
tions in global cognitive functioning (i.e., 22% of the
total variance in cognitive functioning) in a group of
older adults under long-term treatment for depres-
sion. We also replicated previous findings of increased
age and lower educational attainment being related to
lower global cognitive functioning (Plassman et al.,
1995). Consistent with our first hypothesis, we found
that higher levels of chronic depressive symptoms are
related to lower global cognitive functioning (Dotson
et al., 2008; Ganguli et al., 2006; Lichtenberg et al.,
1995; Vinkers et al., 2004). In support to our second
hypothesis and unique to the current investigation,
we discovered that acute fluctuations in depressive
symptomology were associated with fluctuations in
global cognitive functioning (and vice versa) in older
adults under treatment for MDD. Our third
hypothesis was not supported. We did not observe a
1-year longitudinal relationship between depressive
symptoms and cognitive functioning (or vice versa)
in older adults in treatment for MDD. Stated differ-
ently, in our sample of clinically depressed older
adults, the course of depressive symptoms and cogni-
tive functions appear to be tightly temporally related
(i.e., when an individual experiences depressive symp-
toms above their own personal average, they experi-
ence cognitive functioning below their own personal
average). Neither depressive symptoms nor cognitive
functioning at one occasion predicted subsequent level
of functioning 1 year later.
The finding that higher chronic levels of depressive
symptoms are associated with lower levels of global
cognitive functioning adds to a growing literature that
recognizes the importance of depression on late-life
cognitive functioning (Dotson et al., 2008; Han et al.,
2006; Wilson et al., 2004). Importantly, our results
were found in a sample of older adults with formal
Table 2 Multilevel Models Predicting Cognitive Functioning from Depression.
Concurrent Model Lagged Model
Fixed Effects
Predictor Variable B SE df t B SE df t
Within-person (Level 1)
Linear time 2.45 2.24 845.67 1.09 13.56 6.69 179.49 2.03*
Quadratic time 0.51 0.24 163.42 2.14* -0.67 0.62 116.86 -1.08
Age × Linear time -0.03 0.03 854.69 -1.02 -0.19 0.09 184.60 -2.01*
Age × Quadratic -0.01 0.003 167.38 -2.32* 0.01 0.01 119.47 1.08
Depression -0.11 0.03 152.13 -3.41** 0.02 0.10 23.55 0.19
Between-person (Level 2)
Age -0.31 0.10 484.10 -3.03** -0.07 0.24 317.83 -0.28
Sex 0.93 1.26 273.00 0.74 1.50 1.81 80.21 0.83
Education 1.54 0.23 284.66 6.65*** 1.34 0.39 96.10 3.43***
Depression -0.37 0.10 293.53 -3.77*** -0.40 0.17 79.80 -2.31*
Random Effects
Covariance parameter estimate B SE Z B SE Z
Within-person
Linear time .85 .27 3.17** .22 .21 1.03
Quadratic time .003 .002 1.55 .000a .000 a ---
Depression .04 .02 2.38* .23 .18 1.30
Within Pseudo R2 43% Within Pseudo R2 50%
Between Pseudo R2 40% Between Pseudo R2 49%
Note: Cognitive functioning is operationalized as cognitive test performance. Between-person depression refers to person-mean level of the
MADRS (i.e., average level of depression over the entire study period); In the Concurrent Model within-person depression refers to
person-centered level of the MADRS (i.e., annual deviations in depression centered around person-mean level of depression); In the Lagged Model
within-person depression refers to lagged person-centered level of the MADRS (i.e., previous year annual deviations in depression centered around
person-mean level of depression).
a Variance too small to be estimated. The final Hessian matrix is not positive definite although all convergence criteria are satisfied. The test statistic
and confidence interval cannot be computed.
*** Predictor is significant at .001 level;
** Predictor is significant at the .01 level;
* Predictor is significant at the .05 level.
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diagnosis and treatment for MDD, which extends previ-
ous relationships found in preclinical mood disorders.
Previous longitudinal examinations report that
baseline depressive symptoms predict negative
changes in late-life cognitive functioning (Dotson
et al., 2008; van den Kommer et al., 2013; Wilson
et al., 2004) and that baseline cognitive functioning
predicts negative changes in late-life depressive symp-
toms (Jajodia & Borders, 2011; Perrino et al., 2008;
van den Kommer et al., 2013; Vinkers et al., 2004).
In the present study, we did not observe this longitu-
dinal relationship, in either direction. A distinction
between the present sample and those analyzed in
other investigations is that our sample met criteria
for MDD at baseline and subsequently underwent
treatment for MDD. Perhaps the relationship between
depressive symptoms and cognitive functioning is dis-
tinct between subclinical and clinical depressive symp-
toms and may differ when older adults are actively
engaged in treatment and potentially transition from
clinically depressed to not depressed. Future research
should explore this possibility.
Previous investigations did not actively account for
the fluctuating nature of late-life depressive symp-
toms. Late-life depressive symptoms are not static; in
fact, late-life depression displays substantial changes
across time within older adults (Beekman et al.,
2002; Dautovich et al., 2014). In this case, we found
that deviations around an older adult’s average level
of depressive symptoms was associated with fluctua-
tions in their global cognitive functioning even when
participants were actively engaged in treatment for
their depression. In other words, acute changes in
late-life depressive symptoms are associated with
changes in late-life global cognitive functioning in
older adults diagnosed and receiving treatment for
MDD. Such a finding contributes to our understand-
ing that late-life MDD is a cognitive disorder and a
mood disorder, and their etiology and pathogenesis
may be linked.
Table 3 Multilevel models predicting depression from cognitive functioning
Concurrent model Lagged model
Fixed effects
Predictor variable B SE df t B SE df t
Within-person (Level 1)
Linear time 13.62 2.14 551.59 6.35*** 8.89 5.56 143.76 1.60
Quadratic time 1.30 0.21 95.71 6.24*** 0.63 0.53 63.31 1.17
Age × Linear time 0.16 0.03 579.78 5.20*** 0.12 0.08 155.10 1.56
Age ×Quadratic 0.02 0.003 99.86 5.61*** 0.01 0.01 67.33 1.13
Cognitive functioning 0.14 0.04 123.27 3.10** 0.01 0.07 236.49 0.17
Between-person (Level 2)
Age 0.36 0.08 581.16 4.44*** 0.23 0.19 310.62 1.22
Sex 0.98 0.77 210.99 1.27 1.74 1.08 110.84 1.61
Education 0.05 0.15 236.04 0.32 0.01 0.25 125.42 0.04
Cognitive functioning 0.14 0.04 228.17 3.97*** 0.09 0.05 142.42 1.72
Random effects
Covariance parameter estimate B SE Z B SE Z
Within-person
Linear time 0.08 0.10 0.76 0.03 0.10 0.29
Quadratic time 0.0004 0.001 0.47 0.000a 0.000a —
Cognitive functioning 0.08 0.03 2.52* 0.000a 0.000a —
Within pseudo R2 33% Within pseudo R2 59%
Between pseudo R2 2% Between pseudo R2 9%
Cognitive functioning is operationalized as cognitive test performance. Between-person cognitive function refers to person-mean level of the CERAD
neuropsychological battery (i.e., average level of cognitive function over the entire study period). In the concurrent model, within-person cognitive
function refers to person-centered level of CERADneuropsychological battery (i.e., annual deviations in cognitive function centered around person-
mean level of cognitive function). In the lagged model, within-person cognitive function refers to lagged person-centered level of the CERAD
neuropsychological battery (i.e., previous year annual deviations in cognitive function centered around person-mean level of cognitive function).
aVariance too small to be estimated. The final Hessian matrix is not positive definite although all convergence criteria are satisfied. The test statistic
and confidence interval cannot be computed.
***Predictor is significant at 0.001 level;
**Predictor is significant at the 0.01 level;
*Predictor is significant at the 0.05 level.
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There are several clinical implications of the current
investigation. Mood and cognition are dynamically re-
lated concurrently in depressed older adults in treat-
ment for MDD. As such, older adults with comorbid
late-life depression and cognitive difficulties should
engage in pharmacotherapy and/or psychotherapy in
an attempt not only to improve their affective state
but also to indirectly improve their immediate cogni-
tive functioning. Research suggests that medication
treatment of depressive symptoms in late-life can have
a positive impact on cognitive functioning (Butters
et al., 2000; Doraiswamy et al., 2003); however, the ef-
fects of psychotherapy for late-life depression on cog-
nitive functioning remains underexplored.
The concomitant hypothesis of depression and
cognition in late-life posits that a common factor
may be causing both the depressive symptoms and
cognitive dysfunction. As we identified concurrent
associations between depressive symptoms and cog-
nitive functioning in older adults with MDD, our re-
sults provide support for the concomitant hypothesis.
We observed neither a lagged relationship from de-
pressive symptoms to subsequent cognitive function-
ing or from cognitive functioning to subsequent
depressive symptoms. Such data suggest that the fo-
cus of treatment be on immediate and current im-
provements in functioning as opposed to long-term
prevention.
Some limitations of the current study should be
noted. First, data were gathered from depressed older
adults whom all were actively engaged in treatment,
and individuals were treated with several different
psychotropic medications and combinations of medica-
tions. Most individuals were treated with a selective
serotonin-reuptake inhibitor as a first-line treatment,
with changes in treatment procedures based on the
treatment response and the Duke Somatic Treatment
Algorithm for Geriatric Depression (Steffens et al.,
2002). We are limited in our ability to analyze
potential effects of single antidepressant agents over
individual longitudinal courses of treatment; however,
evidence suggests most antidepressant medications have
small-to-nonexistent direct effects on neurocognitive
performance (Podewils and Lyketsos, 2002; Siepmann
et al., 2003). Second, while we did observe relationships
between our variables of interest from year to year, per-
haps annual measurement is not the ideal time frame to
study the link between mood and cognitive functioning
in late-life. Future studies should collect data inmultiple
time samples in order tomore finelymodel the relation-
ships between mood and cognitive functioning. Third,
the CERAD-TS lacks measures of processing speed,
which tends to persist with depression remission. It
would be useful to track dynamic changes in processing
speed and depression symptoms using an analogous
modeling approach. Fourth, the presence of anxiety dis-
orders, which often are comorbid with MDD, and other
medical conditions/lifestyle factors with known rela-
tionships between mood symptoms and cognitive func-
tioning were not accounted for within the current
investigation. Lastly, generalizability may be limited by
the highly educated nature of our clinical sample.
We discovered both a chronic and dynamic concur-
rent relationship between depressive symptoms and
cognitive functioning (and vice versa) in older adults
undergoing treatment for late-life MDD. The dynamic
association between mood disturbance and late-life
cognitive functioning suggests that above and beyond
any cumulative effects of chronic mood on cognitive
functioning in late-life, relatively short-term changes
in mood can still impact cognitive functioning. Such
a finding speaks importantly to the potential plasticity
and resiliency of cognition in older adults who have
experienced depression in later life, as well as to the
importance of mental wellness for cognitive function-
ing in older adults.
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